Prevalence of serotype and multidrug-resistance of Streptococcus pneumoniae respiratory tract isolates in 265 adults and 36 children in Korea, 2002-2005

Microbial Drug Resistance

Volumn 16, Issue 2, 2010, Pages 135-142

  Lee, Sungkyoung ^a   Lee, Kwangjun ^a   Kang, Yeonho ^a   Bae, Songmee ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; SPARFLOXACIN; TETRACYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; FEMALE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROPREVALENCE; SEROTYPE; SOUTH KOREA; STREPTOCOCCUS PNEUMONIAE; CLASSIFICATION; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; KOREA; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; NEWBORN; PNEUMOCOCCAL INFECTIONS; PRESCHOOL CHILD; PREVALENCE; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; SEROTYPING; VERY ELDERLY; YOUNG ADULT;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KOREA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PREVALENCE; RESPIRATORY SYSTEM; RESPIRATORY TRACT INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 77953630357     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2009.0114     Document Type: Article

References (29)

1. Adam, H.J., K.N. Schurek, K.A. Nichol, C.J. Hoban, T.J. Baudry, N.M. Laing, D.J. Hoban, and G.G. Zhanel. 2007. Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005. Antimicrob. Agents Chemother. 51:198-207.
2. Aguiar, S.I., I. Serrano, F.R. Pinto, J. Melo-Cristino, and M. Ramirez on behalf of the Portuguese Surveillance Group for the Study of Respiratory Pathogens. 2008. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Clin. Microbiol. Infect. 14:835-843.
3. Alou, L., M. Ramirez, C. Garcia-Rey, J. Prieto, and H. de Lencastre. 2001. Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin- resistant epidemic clones. Antimicrob. Agents Chemother. 45:2955-2957.
4. Appelbaum, P.C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
5. Bae, S.M., and K.J. Lee. 2009. Distribution of capsular serotypes and macrolide resistance mechanisms among macrolide-resistant Streptococcus pneumoniae isolates in Korea. Diagn. Microbiol. Infect. Dis. 63:213-216.
6. Bruce, M.G. 2008. International circumpolar surveillance system for invasive pneumococcal disease, 1999-2005. Emerg. Infect. Dis. 14:25-33.
7. Carvalho M.D.G., F.C. Pimenta, R.E. Gertz, H.H. Joshi, A.A. Trujillo, L.E. Keys, J. Findley, I.S. Moura, I.H. Park, S.K. Hollingshead, T. Pilishvili, C.G. Whitney, M.H. Nahm, and B.W. Beall for Active Bacterial Core Surveillance Team. 2009. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J. Clin. Microbial. 47:554-559.
8. Choi, E.M., S.H. Kim, B.W. Eun, S.J. Kim, N.H. Kim, J. Lee, and H.J. Lee. 2008. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14:275-281.
9. Clinical and Laboratory Standards Institute. 2008. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational supplement M100-S16. Wayne, Pennsylvania.
10. Critchley, I.A., R.S. Blosser-Middleton, M.E. Jones, J.A. Karlowsly, E.A. Karginova, C. Thornsberry, and D.F. Saham. 2002. Phenotypic and genotypic analysis of levofloxacinresistant clinical isolates of Streptococcus pneumoniae collected in 13 countries during 1999-2000. Int. J. Antimicrob. Agents. 20:100-107.
11. Dagan, R., and K.P. Klugman. 2008. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet 8:785-795.
12. Deshpande, L.M., H.S. Sader, E. Debbia, G. Nicoletti, G. Fadda, and R.N. Jones. 2006. Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial surveillance program (2001-2004). Diagn. Microbiol. Infect. Dis. 54:157-164.
13. Farrell, D.J., K.D. Klugman, and M. Pichichero. 2007. Increased antimicrobial resistance among nonvaccine serotype of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr. Infect. Dis. J. 26:123-128.
14. Ferrara, A.M. 2005. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance. Infection 33:106-114.
15. French, N. 2003. Use of pneumococcal polysaccharide vaccines: no simple answers. J. Infect. 46:78-86.
16. Ho, P.L., R.W.H. Yung, D.N.C. Tsang, T.L. Que, M. Ho, W.H. Seto, T.K. Ng, W.C. Yam, and W.W.S. Ng. 2001. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrobiol. Chemother. 48:659-665.
17. Ishida, T., K. Maniwa, H. Kaquioka, M. Hirabayashi, K. Onaru, H. Tomioka, M. Hayashi, K. Tomii, I. Gohma, Y. Ito, T. Hirai, I. Ito, and M. Mishima. 2008. Antimicrobial susceptibilities of Streptococcus pneumoniae isolated from adults patients with community-aquired pneumonia in Japan. Respirology 13:240-246.
18. Kasahara K., K. Maeda, K. Mikasa, K. Uno, K. Takahashi, M. Konishi, E. Yoshimoto, K. Murakawa, E. Kita, and H. Kimura. 2005. Clonal dissemination of microlide-resistant and penicillin-susceptibile serotype 3 and penicilin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a Pilot Surveillance Study. J. Clin. Microbial. 43:1640-1645.
19. Klugman, K.P. 2003. The role of clonality in the global spread of fluoroquinolone-resistant bacteria. Clin. Infect. Dis. 36:783-785.
20. Klugman, K.P., and K.J. Welsh. 2005. Nasopharyngeal carriage of pneumococcal pediatric serotypes; a risk for acute and recurrent otitis media in children and for invasive disease in susceptible adults. J. Infect. Dis. 191:1790-1792.
21. Kyaw, M.H., R. Lynfield, W. Schaffner, A.S. Craig, J. Hadler, A. Reingold, A.R. Thomas, L.H. Harrison, N.M. Bennett, M.M. Farley, R.R. Facklam, J.H. Jorgensen, J. Besser, E.R. Zell, A. Schuchat, and C.G. Whitney; Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2006. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N. Engl. J. Med. 354:1455-1463.
22. Lee, K.J., S.M. Bae, K.J. Hwang, Y.H. Lee, and K.S. Kim. 2002. Comparative bactericidal activities of fluoroquinolones against penicillin-resistant Streptococcus pneumoniae. J. Kor. Soc. Chemother. 20:253-262.
23. Pai, R., M.R. Moore, T. Pilishivili, R.E. Gertz, C.G. Whitney, and B. Beall; Active Bacterial Core Surveillance Team. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995.
24. Pichichero, M.E., and J.R. Casey. 2007. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298:1772-1778.
25. Shin, J.H., H.J. Jung, H.R. Kim, J. Jeong, S.H. Jeong, S.J. Kim, S.Y. Lee, J.N. Lee, and C.L. Chang. 2007. Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Kroea. Antimicrob. Agents Chemother. 51:2625-2627.
26. Song, J.H., S.I. Jung, K.S. Ko, N.Y. Kim, J.S. Son, H.H. Chang, H.K. Ki, W.S. Oh, J.Y. Suh, K.R. Peck, N.Y. Lee, Y. Yang, Q. Lu, A. Chongthaleong, C.H. Chiu, M.K. Lalitha, J. Perera, T.T. Yee, G. Kumarasinghe, F. Jamal, A. Kamarulzaman, N. Parasakthi, P.H. Van, C. Carlos, T. So, T.K. Ng, and A. Shibl. 2004. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob. Agents Chemother. 48:2101-2107. (Pubitemid 38691605)
27. Stephens, D.S., S.M. Zughaier, C.G. Whitney, W.S. Baughman, L. Barker, K. Gay, D. Jackson, W.A. Orenstein, K. Arnold, A. Schuchat, and M.M. Farley; Georgia Emerging Infections Program. 2005. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment. Lancet 365:855-863.
28. Talbot, T.R., K.A. Poehling, T.V. Hartert, P.G. Arboqast, N.B. Halasa, E. Mitchel, W. Schaffner, A.S. Craq, K.M. Edwards, and M.R. Griffin. 2004. Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in Tenessee after introduction of the pneumococcal conjugate vaccine. Clin. Infect. Dis. 39:614-618.
29. Whitney, C.G., M.M. Farley, J. Hadler, L.H. Harrison, N.M. Bennett, R. Lynfield, A. Reingold, P.R. Cieslak, T. Pilishvili, D. Jackson, R.R. Facklam, J.H. Jorgensen, and A. Schuchat; Active Bacterial Core Surveillance of the Emerging Infection Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746. (Pubitemid 36514704)